Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-36,000
| Closed | -$1.55M | – | 5407 |
|
|
2025
Q3 | $1.55M | Buy |
+36,000
| New | +$1.41M | ﹤0.01% | 3065 |
|
|
2022
Q1 | – | Sell |
-4,720
| Closed | -$260K | – | 5221 |
|
|
2021
Q4 | $260K | Hold |
4,720
| – | – | ﹤0.01% | 3471 |
|
|
2021
Q3 | $225K | Hold |
4,720
| – | – | ﹤0.01% | 3554 |
|
|
2021
Q2 | $235K | Hold |
4,720
| – | – | ﹤0.01% | 3467 |
|
|
2021
Q1 | $211K | Sell |
4,720
-7,520
| -61% | -$341K | ﹤0.01% | 3682 |
|
|
2020
Q4 | $563K | Hold |
12,240
| – | – | ﹤0.01% | 3169 |
|
|
2020
Q3 | $576K | Hold |
12,240
| – | – | ﹤0.01% | 3133 |
|
|
2020
Q2 | $624K | Sell |
12,240
-59,360
| -83% | -$3.05M | ﹤0.01% | 3161 |
|
|
2020
Q1 | $3.39M | Buy |
71,600
+39,520
| +123% | +$2.11M | ﹤0.01% | 1802 |
|
|
2019
Q4 | $1.88M | Sell |
32,080
-19,520
| -38% | -$1.09M | ﹤0.01% | 3068 |
|
|
2019
Q3 | $2.75M | Buy |
51,600
+25,600
| +98% | +$1.32M | ﹤0.01% | 2479 |
|
|
2019
Q2 | $1.3M | Buy |
26,000
+8,160
| +46% | +$409K | ﹤0.01% | 3408 |
|
|
2019
Q1 | $932K | Sell |
17,840
-27,200
| -60% | -$1.36M | ﹤0.01% | 3477 |
|
|
2018
Q4 | $2.15M | Sell |
45,040
-6,560
| -13% | -$323K | ﹤0.01% | 2336 |
|
|
2018
Q3 | $2.59M | Sell |
51,600
-100,480
| -66% | -$5.11M | ﹤0.01% | 2568 |
|
|
2018
Q2 | $7.66M | Buy |
152,080
+98,560
| +184% | +$4.96M | 0.01% | 1417 |
|
|
2018
Q1 | $2.61M | Sell |
53,520
-960
| -2% | -$44.7K | ﹤0.01% | 2223 |
|
|
2017
Q4 | $2.42M | Sell |
54,480
-48,000
| -47% | -$2.22M | ﹤0.01% | 2267 |
|
|
2017
Q3 | $5.2M | Buy |
102,480
+51,440
| +101% | +$2.61M | 0.01% | 1503 |
|
|
2017
Q2 | $2.75M | Buy |
51,040
+16,480
| +48% | +$879K | ﹤0.01% | 1970 |
|
|
2017
Q1 | $1.82M | Sell |
34,560
-67,200
| -66% | -$3.41M | ﹤0.01% | 2180 |
|
|
2016
Q4 | $4.9M | Buy |
101,760
+25,760
| +34% | +$1.27M | 0.01% | 1386 |
|
|
2016
Q3 | $4.1M | Sell |
76,000
-101,200
| -57% | -$5.55M | ﹤0.01% | 1442 |
|
|
2016
Q2 | $9.6M | Buy |
177,200
+152,480
| +617% | +$8.03M | 0.01% | 864 |
|
|
2016
Q1 | $1.24M | Sell |
24,720
-21,360
| -46% | -$1.06M | ﹤0.01% | 2356 |
|
|
2015
Q4 | $2.3M | Sell |
46,080
-10,480
| -19% | -$534K | ﹤0.01% | 1909 |
|
|
2015
Q3 | $2.69M | Sell |
56,560
-1,808,080
| -97% | -$94.1M | ﹤0.01% | 1874 |
|
|
2015
Q2 | $95.6M | Sell |
1,864,640
-249,360
| -12% | -$14M | 0.11% | 151 |
|
|
2015
Q1 | $122M | Buy |
2,114,000
+1,956,880
| +1,245% | +$112M | 0.14% | 121 |
|
|
2014
Q4 | $8.25M | Buy |
157,120
+3,360
| +2% | +$188K | 0.01% | 1322 |
|
|
2014
Q3 | $8.65M | Buy |
153,760
+114,000
| +287% | +$6.99M | 0.01% | 1288 |
|
|
2014
Q2 | $2.63M | Buy |
39,760
+13,040
| +49% | +$883K | ﹤0.01% | 2335 |
|
|
2014
Q1 | $1.77M | Sell |
26,720
-16,480
| -38% | -$1.11M | ﹤0.01% | 2663 |
|
|
2013
Q4 | $2.86M | Buy |
43,200
+8,720
| +25% | +$565K | ﹤0.01% | 2313 |
|
|
2013
Q3 | $2.15M | Sell |
34,480
-179,920
| -84% | -$11.6M | ﹤0.01% | 2478 |
|
|
2013
Q2 | $13.4M | Buy |
+214,400
| New | +$13.6M | 0.02% | 874 |
|
Other funds holding GSK
JEST
Barclays's GSK Position: Q1 2026 in Review
Barclays increased its GSK (GSK) stake by 19,318% in Q1 2026, buying an estimated $20.5M and bringing the position to 380,397 shares worth $21M. The position accounts for 0.01% of the portfolio, ranked #1080.
Barclays first reported a position in GSK in Q2 2013 and has held it in 52 quarters since. The position peaked at $246M in Q1 2015. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- Barclays held 380,397 shares of GSK worth $21M as of Q1 2026.
- Barclays bought 378,438 GSK shares in Q1 2026, an estimated $20.5M.
- GSK made up 0.01% of Barclays's portfolio in Q1 2026, its #1080 holding.
- Barclays first reported a position in GSK in Q2 2013 and has held it in 52 quarters since.
- Barclays's GSK position peaked at $246M in Q1 2015.
- 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.